Laminin 511-E8, an Autoantigen in IgG4-related Cholangitis, Contributes to Cholangiocyte Protection

Overview

Journal JHEP Rep

Specialty Gastroenterology

Date 2024 Mar 25

PMID 38524667

Authors

David C Trampert

Remco Kersten

Dagmar Tolenaars

Aldo Jongejan

Stan F J van de Graaf

Ulrich Beuers

Affiliations

Soon will be listed here.

Abstract

Background & Aims: IgG4-related cholangitis (IRC) is the hepatobiliary manifestation of IgG4-related disease. Anti-laminin 511-E8 autoantibodies have been identified in its pancreatic manifestation. Laminin 511-E8 promotes endothelial barrier function, lymphocyte recruitment, and cholangiocyte differentiation. Here, we investigate anti-laminin 511-E8 autoantibody presence in IRC, and mechanisms via which laminin 511 may contribute to cholangiocyte protection.

Methods: Anti-laminin 511-E8 serum autoantibody positivity was assessed by ELISA. RNA sequencing and RT-qPCR were performed on human H69 cholangiocytes treated with recombinant laminin 511-E8. H69 cholangiocytes were subjected to shRNA knockdown targeting genes encoding laminin 511 (, , ) or treated with recombinant laminin 511-E8. Cholangiocellular bile acid influx was quantified radiochemically using 22,23-H-glycochenodeoxycholic acid (GCDC). GCDC-induced apoptosis was determined by Caspase-3/7 assays. Cholangiocellular barrier function was assessed by FITC-Dextran permeability assays. Immunofluorescent staining of laminin 511 and claudin 1 was performed on extrahepatic bile duct tissue of control and anti-laminin 511-E8 positive individuals with IRC.

Results: Seven out of 52 individuals with IRC had autoantibodies against laminin 511-E8. Recombinant laminin 511-E8 led to differential expression of genes involved in secretion, barrier function, and inflammation. Knockdown of laminin 511 constituents increased toxic bile acid permeation and GCDC-induced apoptosis. Laminin 511-E8 treatment decreased toxic bile acid permeation and dose-dependently alleviated GCDC-induced apoptosis. and knockdown increased transepithelial permeability. Laminin 511-E8 treatment reduced transepithelial permeability and prevented T lymphocyte-induced barrier dysfunction. Laminin 511 and claudin 1 staining patterns appeared altered in anti-laminin 511-E8 positive individuals with IRC.

Conclusions: Laminin 511-E8 is an autoantigen in subsets of individuals with IRC. Laminin 511 enhances cholangiocellular barrier function and protects cholangiocytes against T lymphocyte-induced barrier dysfunction, toxic bile acid permeation and bile acid-induced apoptosis.

Impact And Implications: A subset of patients with IgG4-related cholangitis (IRC) has autoantibodies against laminin 511-E8. In human cholangiocytes, laminin 511 protects against (T lymphocyte-induced) epithelial barrier dysfunction and hydrophobic bile acids. Laminin 511 and claudin 1 staining may be altered in extrahepatic bile ducts of patients with IRC who are anti-laminin 511-E8 positive. This makes it tempting to speculate that a decreased epithelial barrier function with attraction of immune cells and impaired bicarbonate secretion as a result of dysfunction of laminin 511 by autoantibody binding could potentially be a common systemic pathogenic mechanism in a subset of patients with IgG4-RD.

Citing Articles

Update on Autoimmune Pancreatitis and IgG4-Related Disease.

Lanzillotta M, Vujasinovic M, Lohr J, Della Torre E United European Gastroenterol J. 2024; 13(1):107-115.

PMID: 39707927 PMC: 11866317. DOI: 10.1002/ueg2.12738.

Raptinal: a powerful tool for rapid induction of apoptotic cell death.

Smith A, Hergenrother P Cell Death Discov. 2024; 10(1):371.

PMID: 39164225 PMC: 11335860. DOI: 10.1038/s41420-024-02120-1.

References

Motallebnejad P, Azarin S . Chemically defined human vascular laminins for biologically relevant culture of hiPSC-derived brain microvascular endothelial cells. Fluids Barriers CNS. 2020; 17(1):54. PMC: 7488267. DOI: 10.1186/s12987-020-00215-2. View

Maillette de Buy Wenniger L, Doorenspleet M, Klarenbeek P, Verheij J, Baas F, Elferink R . Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. Hepatology. 2013; 57(6):2390-8. DOI: 10.1002/hep.26232. View

. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022; 77(3):761-806. DOI: 10.1016/j.jhep.2022.05.011. View

Omokawa A, Komatsuda A, Hirokawa M, Wakui H . Membranous nephropathy with monoclonal IgG4 deposits and associated IgG4-related lung disease. Clin Kidney J. 2015; 7(5):475-8. PMC: 4379336. DOI: 10.1093/ckj/sfu077. View

Ghazale A, Chari S, Zhang L, Smyrk T, Takahashi N, Levy M . Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008; 134(3):706-15. DOI: 10.1053/j.gastro.2007.12.009. View

Shiokawa M, Kodama Y, Sekiguchi K, Kuwada T, Tomono T, Kuriyama K . Laminin 511 is a target antigen in autoimmune pancreatitis. Sci Transl Med. 2018; 10(453). DOI: 10.1126/scitranslmed.aaq0997. View

Maillette de Buy Wenniger L, Culver E, Beuers U . Exposure to occupational antigens might predispose to IgG4-related disease. Hepatology. 2014; 60(4):1453-4. PMC: 4258085. DOI: 10.1002/hep.26999. View

Zimmer A, Pan Y, Chandrapalan T, Kwong R, Perry S . Loss-of-function approaches in comparative physiology: is there a future for knockdown experiments in the era of genome editing?. J Exp Biol. 2019; 222(Pt 7). DOI: 10.1242/jeb.175737. View

El-Brolosy M, Stainier D . Genetic compensation: A phenomenon in search of mechanisms. PLoS Genet. 2017; 13(7):e1006780. PMC: 5509088. DOI: 10.1371/journal.pgen.1006780. View

10.

Muller T, Beutler C, Pico A, Otten M, Durr A, Al-Abadi H . Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier. Gastroenterology. 2013; 144(5):1116-28. DOI: 10.1053/j.gastro.2013.01.055. View

11.

Zhang X, Wang Y, Song J, Gerwien H, Chuquisana O, Chashchina A . The endothelial basement membrane acts as a checkpoint for entry of pathogenic T cells into the brain. J Exp Med. 2020; 217(7). PMC: 7336306. DOI: 10.1084/jem.20191339. View

12.

Lohr J, Beuers U, Vujasinovic M, Alvaro D, Frokjaer J, Buttgereit F . European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterol J. 2020; 8(6):637-666. PMC: 7437085. DOI: 10.1177/2050640620934911. View

13.

Shiokawa M, Kodama Y, Kuriyama K, Yoshimura K, Tomono T, Morita T . Pathogenicity of IgG in patients with IgG4-related disease. Gut. 2016; 65(8):1322-32. DOI: 10.1136/gutjnl-2015-310336. View

14.

Min S, Wu L, Zhang Y, Zhu W, Cong X, Yu G . Disruption of tight junction structure contributes to secretory dysfunction in IgG4-related sialadenitis. J Mol Histol. 2019; 51(1):33-46. DOI: 10.1007/s10735-019-09854-8. View

15.

Yoshikawa T, Minaga K, Hara A, Sekai I, Kurimoto M, Masuta Y . Disruption of the intestinal barrier exacerbates experimental autoimmune pancreatitis by promoting the translocation of Staphylococcus sciuri into the pancreas. Int Immunol. 2022; 34(12):621-634. DOI: 10.1093/intimm/dxac039. View

16.

Abe A, Takano K, Kojima T, Nomura K, Kakuki T, Kaneko Y . Interferon-gamma increased epithelial barrier function via upregulating claudin-7 expression in human submandibular gland duct epithelium. J Mol Histol. 2016; 47(3):353-63. DOI: 10.1007/s10735-016-9667-2. View

17.

Kizhakeyil A, Ong S, Fazil M, Chalasani M, Prasannan P, Verma N . Isolation of Human Peripheral Blood T-Lymphocytes. Methods Mol Biol. 2019; 1930:11-17. DOI: 10.1007/978-1-4939-9036-8_2. View

18.

Wu C, Ivars F, Anderson P, Hallmann R, Vestweber D, Nilsson P . Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med. 2009; 15(5):519-27. DOI: 10.1038/nm.1957. View

19.

Hubers L, Vos H, Schuurman A, Erken R, Elferink R, Burgering B . Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut. 2017; 67(4):728-735. DOI: 10.1136/gutjnl-2017-314548. View

20.

Mattoo H, Mahajan V, Della-Torre E, Sekigami Y, Carruthers M, Wallace Z . De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014; 134(3):679-87. PMC: 4149918. DOI: 10.1016/j.jaci.2014.03.034. View